Advertisements

Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)
$ 0.1601   -0.0149 (-8.51%) Volume: 68.93k 4:00 PM EST Feb 5, 2016
Today 5d 1m 3m 1y more
Last Price
0.1601
Change $
0.0149
Change %
8.51%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.16
High
0.1799
Low
0.16
Prev Close
0.175
Last Trade
02/05/16
Volume
68.93k
52 Wk Hi
3.751
52 Wk Low
0.1401
Market Cap
5.19m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
32,406,671
EPS (TTM)
-0.69
PE Ratio
N/A
Exchange
NCM
News and Media for Lpath Inc. (LPTN)
Sector News | Topic News
News for Lpath Inc. (LPTN)
Mon, Feb 01, 2016
8:00 AM Lpath Completes Dosing in the Lpathomab Phase 1 Safety Study - PR Newswire
Mon, Jan 25, 2016
7:42 AM Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club - SeekingAlpha
Mon, Nov 16, 2015
8:00 AM Lpath to Hold Corporate Update Conference Call and Live Webcast on Tuesday, November 17th - PR Newswire
Thu, Nov 05, 2015
8:00 AM Lpath to Present Nexus Phase 2 Study Data in Wet Age-Related Macular Degeneration at the 2015 American Academy of Ophthalmology Annual Meeting Retinal Subspecialty Day - PR Newswire
Tue, Sep 29, 2015
4:05 PM Lpath Appoints Gary Atkinson Interim Chief Executive Officer - PR Newswire
Tue, Sep 15, 2015
8:00 AM Lpath Initiates First-in-Human Dosing in Phase 1 Clinical Trial of Lpathomab - PR Newswire
Tue, Sep 01, 2015
8:00 AM Biotech Weekly: Reviewing The - SeekingAlpha
Wed, May 20, 2015
1:14 PM Lpath's lead product candidate fails Phase 2 study; shares plunge 80% - SeekingAlpha
12:45 PM Midday Gainers / Losers - SeekingAlpha
9:14 AM Premarket Gainers / Losers as of 9:10 am - SeekingAlpha
Wed, Mar 25, 2015
12:45 PM Midday Gainers / Losers - SeekingAlpha
Tue, Mar 24, 2015
5:34 PM Lpath kidney cancer drug candidate fails in study; shares off 27% after hours - SeekingAlpha
Wed, Mar 11, 2015
2:41 PM Cleveland BioLabs: A Reverse Split Low Floater With Catalysts - SeekingAlpha
Sat, Mar 07, 2015
6:15 AM Lpath: A Binary Situation With Odds In Investors' Favor - SeekingAlpha
Tue, May 27, 2014
9:52 PM Is Lpath Inc. a Savior from Blindness? - Equities.com
Thu, Oct 17, 2013
8:52 AM Five Star Equities Issues New Research Reports on ARIA, CGIX, CYTR and LPTN - Accesswire
Thu, Mar 01, 2012
7:19 AM Keeping an eye on Lpath as shares look to build momentum - Accesswire
Tue, Dec 06, 2011
11:13 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
11:06 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
Thu, Dec 01, 2011
2:11 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody